Skip to content

Clinical trials

Active, not recruiting Carcinoma, Non-Small-Cell Lung trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Active, not recruiting Country / region: United States Clear all

338 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20111
20122
20133
20145
20159
201617
201720
201825
201938
202041
202139
202249
202341
202434
202510
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting338

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca31
National Cancer Institute (NCI)22
M.D. Anderson Cancer Center19
Janssen Research & Development, LLC10
Eli Lilly and Company9
Merck Sharp & Dohme LLC9
Bristol-Myers Squibb8
Daiichi Sankyo8
Novartis Pharmaceuticals7
Pfizer6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung338
Lung Neoplasms94
Colorectal Neoplasms47
Melanoma42
Carcinoma, Renal Cell31
Squamous Cell Carcinoma of Head and Neck31
Neoplasms30
Neoplasm Metastasis29
Ovarian Neoplasms29
Stomach Neoplasms24

Trials

Showing 1 to 25 of 338. Each trial links to its page on Pharma Observatory.

238 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.